Page 268 - Read Online
P. 268

Page 22 of 23                         Parsons et al. J Cancer Metastasis Treat 2018;4:19  I  http://dx.doi.org/10.20517/2394-4722.2018.11

                   progression. J Biol Chem 2013;288:11572-80.
               178. Shi C, Ren L, Sun C, Yu L, Bian X, Zhou X, Wen Y, Hua D, Zhao S, Luo W, Wang R, Rao C, Wang Q, Yu S. MiR-29a/b/c function as
                   invasion suppressors for gliomas by targeting CDC42 and predict the prognosis of patients. Br J Cancer 2017;117:1036-47.
               179. Qiu F, Sun R, Deng N, Guo T, Cao Y, Yu Y, Wang X, Zou B, Zhang S, Jing T, Ling T, Xie J, Zhang Q. MiR-29a/b enhances cell
                   migration and invasion in nasopharyngeal carcinoma progression by regulating SPARC and COL3A1 gene expression. PLoS One
                   2015;10:e0120969.
               180. Gooding AJ, Zhang B, Jahanbani FK, Gilmore HL, Chang JC, Valadkhan S, Schiemann WP. The lncRNA BORG drives breast cancer
                   metastasis and disease recurrence. Sci Rep 2017;7:12698.
               181. Addison JB, Koontz C, Fugett JH, Creighton CJ, Chen D, Farrugia MK, Padon RR, Voronkova MA, McLaughlin SL, Livengood RH,
                   Lin CC, Ruppert JM, Pugacheva EN, Ivanov AV. KAP1 promotes proliferation and metastatic progression of breast cancer cells. Cancer
                   Res 2015;75:344-55.
               182. Lee YK, Thomas SN, Yang AJ, Ann DK. Doxorubicin down-regulates Krüppel-associated box domain-associated protein 1 sumoylation
                   that relieves its transcription repression on p21WAF1/CIP1 in breast cancer MCF-7 cells. J Biol Chem 2007;282:1595-606.
               183. Prensner JR, Chen W, Han S, Iyer MK, Cao Q, Kothari V, Evans JR, Knudsen KE, Paulsen MT, Ljungman M, Lawrence TS, Chinnaiyan
                   AM, Feng FY. The long non-coding RNA PCAT-1 promotes prostate cancer cell proliferation through cMyc. Neoplasia 2014;16:900-8.
               184. Prensner JR, Chen W, Iyer MK, Cao Q, Ma T, Han S, Sahu A, Malik R, Wilder-Romans K, Navone N, Logothetis CJ, Araujo JC, Pisters
                   LL, Tewari AK, Canman CE, Knudsen KE, Kitabayashi N, Rubin MA, Demichelis F, Lawrence TS, Chinnaiyan AM, Feng FY. PCAT-1,
                   a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer. Cancer Res 2014;74:1651-60.
               185. Feng FY, Prensner JR, Chen W, Iyer MK, Cao Q, Wilder-Romans K, Lawrence TS, Chinnaiyan AM. A tissue-specific long noncoding
                   RNA controls homologous recombination in prostate cancer. Int J Radiat Oncol 2012;84:S176.
               186. Guo H, Ahmed M, Zhang F, Yao CQ, Li S, Liang Y, Hua J, Soares F, Sun Y, Langstein J, Li Y, Poon C, Bailey SD, Desai K, Fei T,
                   Li Q, Sendorek DH, Fraser M, Prensner JR, Pugh TJ, Pomerantz M, Bristow RG, Lupien M, Feng FY, Boutros PC, Freedman ML,
                   Walsh MJ, He HH. Modulation of long noncoding RNAs by risk SNPs underlying genetic predispositions to prostate cancer. Nat Genet
                   2016;48:1142-50.
               187. Gardini A. Global run-on sequencing (GRO-Seq). Methods Mol Biol 2017;1468:111-20.
               188. Chi SW, Zang JB, Mele A, Darnell RB. Ago HITS-CLIP decodes miRNA-mRNA interaction maps. Nature 2009;460:479-86.
               189. Helwak A, Kudla G, Dudnakova T, Tollervey D. Mapping the human miRNA interactome by CLASH reveals frequent noncanonical
                   binding. Cell 2013;153:654-65.
               190. Tano K, Mizuno R, Okada T, Rakwal R, Shibato J, Masuo Y, Ijiri K, Akimitsu N. MALAT-1 enhances cell motility of lung
                   adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett 2010;584:4575-80.
               191. Ji P, Diederichs S, Wang W, Böing S, Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, Thomas M, Berdel WE, Serve
                   H, Müller-Tidow C. MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell
                   lung cancer. Oncogene 2003;22:8031-41.
               192. Ying L, Chen Q, Wang Y, Zhou Z, Huang Y, Qiu F. Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing
                   epithelial-to-mesenchymal transition. Mol Biosyst 2012;8:2289-94.
               193. Zhang Y, Wang L, Li N, Dai H, Sun J, Cai HF. Downregulation of long non-coding RNA MALAT1 induces tumor progression of human
                   breast cancer through regulating CCND1 expression. Open Life Sci 2016;11:232-6.
               194. Liu JH, Chen G, Dang YW, Li CJ, Luo DZ. Expression and prognostic significance of lncRNA MALAT1 in pancreatic cancer tissues.
                   Asian Pac J Cancer Prev 2014;15:2971-7.
               195. Zhou Y, Zhang X, Klibanski A. MEG3 noncoding RNA: a tumor suppressor. J Mol Endocrinol 2012;48:R45-53.
               196. Xiu YL, Sun KX, Chen X, Chen S, Zhao Y, Guo QG, Zong ZH. Upregulation of the lncRNA Meg3 induces autophagy to inhibit
                   tumorigenesis and progression of epithelial ovarian carcinoma by regulating activity of ATG3. Oncotarget 2017;8:31714-25.
               197. Zhou Y, Zhong Y, Wang Y, Zhang X, Batista DL, Gejman R, Ansell PJ, Zhao J, Weng C, Klibanski A. Activation of p53 by MEG3 non-
                   coding RNA. J Biol Chem 2007;282:24731-42.
               198. Lu KH, Li W, Liu XH, Sun M, Zhang ML, Wu WQ, Xie WP, Hou YY. Long non-coding RNA MEG3 inhibits NSCLC cells proliferation
                   and induces apoptosis by affecting p53 expression. BMC Cancer 2013;13:461.
               199. Peng W, Si S, Zhang Q, Li C, Zhao F, Wang F, Yu J, Ma R. Long non-coding RNA MEG3 functions as a competing endogenous RNA to
                   regulate gastric cancer progression. J Exp Clin Cancer Res 2015;34:79.
               200. Li H, An J, Wu M, Zheng Q, Gui X, Li T, Pu H, Lu D. LncRNA HOTAIR promotes human liver cancer stem cell malignant growth
                   through downregulation of SETD2. Oncotarget 2015;6:27847-64.
               201. Qiu JJ, Lin YY, Ye LC, Ding JX, Feng WW, Jin HY, Zhang Y, Li Q, Hua KQ. Overexpression of long non-coding RNA HOTAIR
                   predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer. Gynecol Oncol 2014;134:121-8.
               202. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, Wang Y, Brzoska P, Kong B, Li
                   R, West RB, van de Vijver MJ, Sukumar S, Chang HY. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer
                   metastasis. Nature 2010;464:1071-6.
               203. Tao S, He H, Chen Q. Estradiol induces HOTAIR levels via GPER-mediated miR-148a inhibition in breast cancer. J Transl Med
                   2015;13:131.
               204. Kim K, Jutooru I, Chadalapaka G, Johnson G, Frank J, Burghardt R, Kim S, Safe S. HOTAIR is a negative prognostic factor and
                   exhibits pro-oncogenic activity in pancreatic cancer. Oncogene 2013;32:1616-25.
               205. Hu L, Ye H, Huang G, Luo F, Liu Y, Liu Y, Yang X, Shen J, Liu Q, Zhang J. Long noncoding RNA GAS5 suppresses the migration and
   263   264   265   266   267   268   269   270   271   272   273